BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32445345)

  • 1. A Biomarker for Concussion: The Good, the Bad, and the Unknown.
    Reece JT; Milone M; Wang P; Herman D; Petrov D; Shaw LM
    J Appl Lab Med; 2020 Jan; 5(1):170-182. PubMed ID: 32445345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking a Closer Look at the Biomarker Test for Mild Traumatic Brain Injury.
    Voelker R
    JAMA; 2018 May; 319(20):2066-2067. PubMed ID: 29800154
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.
    Bazarian JJ; Biberthaler P; Welch RD; Lewis LM; Barzo P; Bogner-Flatz V; Gunnar Brolinson P; Büki A; Chen JY; Christenson RH; Hack D; Huff JS; Johar S; Jordan JD; Leidel BA; Lindner T; Ludington E; Okonkwo DO; Ornato J; Peacock WF; Schmidt K; Tyndall JA; Vossough A; Jagoda AS
    Lancet Neurol; 2018 Sep; 17(9):782-789. PubMed ID: 30054151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
    Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
    World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
    Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
    Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
    Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
    J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy.
    Mondello S; Shear DA; Bramlett HM; Dixon CE; Schmid KE; Dietrich WD; Wang KK; Hayes RL; Glushakova O; Catania M; Richieri SP; Povlishock JT; Tortella FC; Kochanek PM
    J Neurotrauma; 2016 Mar; 33(6):595-605. PubMed ID: 26671651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury.
    Bazarian JJ; Welch RD; Caudle K; Jeffrey CA; Chen JY; Chandran R; McCaw T; Datwyler SA; Zhang H; McQuiston B
    Acad Emerg Med; 2021 Nov; 28(11):1308-1317. PubMed ID: 34358399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of Blood Biomarkers of Traumatic Brain Injury.
    Rezaii PG; Grant GA; Zeineh MM; Richardson KJ; Coburn ML; Bet AM; Weber A; Jiang B; Li Y; Ubungen K; Routh G; Wheatcroft AM; Paulino AD; Hayes RL; Steinberg GK; Wintermark M
    J Neurotrauma; 2019 Aug; 36(16):2407-2416. PubMed ID: 30968744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers May Predict Unfavorable Neurological Outcome after Mild Traumatic Brain Injury.
    Lewis LM; Papa L; Bazarian JJ; Weber A; Howard R; Welch RD
    J Neurotrauma; 2020 Dec; 37(24):2624-2631. PubMed ID: 32821007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
    Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
    J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
    Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
    EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing blood biomarkers to clinical decision rules to select patients suspected of traumatic brain injury for head computed tomography.
    Li Y; Ding VY; Chen H; Zhu G; Jiang B; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    Neuroradiol J; 2023 Feb; 36(1):68-75. PubMed ID: 35588232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?
    Rhine T; Babcock L; Zhang N; Leach J; Wade SL
    Brain Inj; 2016; 30(10):1231-8. PubMed ID: 27416022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes: Findings From the NCAA and Department of Defense CARE Consortium.
    McCrea M; Broglio SP; McAllister TW; Gill J; Giza CC; Huber DL; Harezlak J; Cameron KL; Houston MN; McGinty G; Jackson JC; Guskiewicz K; Mihalik J; Brooks MA; Duma S; Rowson S; Nelson LD; Pasquina P; Meier TB; ; Foroud T; Katz BP; Saykin AJ; Campbell DE; Svoboda SJ; Goldman J; DiFiori J
    JAMA Netw Open; 2020 Jan; 3(1):e1919771. PubMed ID: 31977061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Blood Biomarkers for Magnetic Resonance Imaging Diagnosis of Traumatic Brain Injury.
    Yue JK; Upadhyayula PS; Avalos LN; Deng H; Wang KKW
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32098419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.